By Deena Beasley SAN DIEGO, June 23 (Reuters) – U.S. biotechnology industry trade group BIO worked with the Food and Drug Administration on plans announced on Monday to speed clinical trials and
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Exclusive-Comcast-owned Sky reaches terms to buy ITV's broadcast unit, sources say
By Paul Sandle and Amy-Jo Crowley LONDON, June 24 (Reuters) - Sky, the Comcast-owned British…
South Korean chip shares surge after Micron flags strong AI-related demand
By Heekyong Yang SEOUL, June 25 (Reuters) - South Korean semiconductor shares rallied on Thursday…
Asian stocks surge as Micron earnings ease AI fears
By Ankur Banerjee SINGAPORE, June 25 (Reuters) - Asian equities surged on Thursday after strong…
